Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Heike WeidnerDepartment of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.ORCID 0009-0001-6045-3349
Ulrike BaschantDepartment of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Maria G Ledesma-ColungaDepartment of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Karolina BasiakDepartment of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.ORCID 0009-0009-6367-8189
Elena TsourdiDepartment of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Katja SockelDepartment of Medicine I, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.ORCID 0000-0003-1732-7299
Katharina S GötzeDepartment of Medicine III, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Jennifer RivièreDepartment of Medicine III, Technical University of Munich, School of Medicine and Health, Munich, Germany.ORCID 0000-0002-4680-2071
Uwe PlatzbeckerGerman Cancer Consortium (DKTK), partner sites Dresden and Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0003-1863-3239
Lorenz C Hofbauer *Department of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Martina Rauner *Department of Medicine III & Center for Healthy Aging, Medical Faculty and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany. martina.rauner@ukdd.de.ORCID 0000-0002-4067-6799
Funding
Deutsche Forschungsgemeinschaft (German Research Foundation) FerrOs FOR5146
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bone marrow transplantation reduces FGF-23 levels and restores bone formation in myelodysplastic neoplasms. · full record | OpenQuestion